These meetings offer an excellent opportunity for companies and institutions to discuss isotope supply and demand issues firsthand with the federal DOE IP Director and Program Managers and the National Isotope Development Center Staff. We look forward to these insightful discussions so we can better serve the isotope community.
NIDC News
DOE Isotope Program Highlights
![Illustration by Christopher Orosco, Oak Ridge National Laboratory Illustration of the structure of the radium compound characterized in this research. Single crystal X-ray diffraction provided detailed information on the bonding of radium in an organic molecule for the first time.](/sites/default/files/styles/center_news_homepage/public/2024-07/Radium-Crystalization-Structure.png?h=305389c3&itok=TbW0JsXy)
A First Look Inside Radium’s Solid-State Chemistry
![Image courtesy of Bobba, K.N., et al., Evaluation of cerium/lanthanum-134 as a PET imaging theranostic pair for 225Ac alpha radiotherapeutics. Journal of Nuclear Medicine 64, 7 (2023). Radiopharmaceuticals based on cerium/lanthanum-134 have promise for prostate cancer imaging and therapy. At right, tumors show high tumor uptake of cerium-134. At left, a comparison of cerium-134 and actinium-225 shows a similar pattern of uptake in most tissues (note the tumor tissue on the leg).](/sites/default/files/styles/center_news_homepage/public/2023-10/IP-2023-08-a%20%281%29.jpg?h=f73afe43&itok=Y6n5kQw_)
Transforming Cancer Diagnosis and Treatment with Cerium/Lanthanum-134
![Image courtesy of Brookhaven National Laboratory Depiction of a titanium-44/scandium-44 generator. The generator consists of a hydroxamate-based resin undergoing scandium-44 elution with hydrochloric acid.](/sites/default/files/styles/center_news_homepage/public/2023-08/IP-2023-07-b.jpg?h=b1c5f207&itok=pn1KCM9H)